GlassScriptPhysician profile
Norman Bebla
NPI 1609824481
$29,837.62
in general payments reported to CMS, 2019-2025
24 companies · $3,937 in 2025
The $3,937 reported for 2025 was more than what 96% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,481 · 2021: $3,230 · 2022: $5,428 · 2023: $2,615 · 2024: $5,146 · 2025: $3,937.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,561 · Travel and Lodging: $2,037 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,560.90 |
| Travel and Lodging | $2,037.37 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,417.32 | 2019-2023 | Da Vinci Surgical System |
| Coloplast Corp | $8,641.71 | 2019-2025 | Restorelle, Altis, Saffron |
| Medtronic, INC. | $2,906.73 | 2022-2024 | Interstim, Enterra II |
| Axonics, INC. | $1,763.63 | 2022-2024 | Axonics, Bulkamid |
| Applied Medical Resources Corporation | $1,187.14 | 2022 | |
| Caldera Medical, INC | $1,044.88 | 2021-2024 | Desara |
| Boston Scientific Corporation | $1,001.41 | 2023-2025 | Bulkamid, Axonics, Solyx Sis System |
| Globus Medical, INC. | $562.44 | 2025 | Senza |
| Nevro Corp. | $530.34 | 2024 | Senza |
| Sumitomo Pharma America, INC. | $166.68 | 2024-2025 | Gemtesa |
| Astellas Pharma US INC | $158.68 | 2023 | Veozah, Myrbetriq |
| Femselect INC. | $137.55 | 2024 | Enplace |
| Merck Sharp & Dohme LLC | $56.01 | 2023-2025 | Keytruda |
| Genmab U.S., INC. | $40.56 | 2024-2025 | Tivdak |
| Octapharma USA, INC. | $32.96 | 2025 | Fibryga |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $25.91 | 2025 | Fetal Fibronectin Enzyme Immunoassay |
| Baxter Healthcare | $25.79 | 2022 | |
| Abbvie INC. | $25.11 | 2022 | |
| Eisai INC. | $24.10 | 2024 | |
| Tela Bio, INC. | $22.55 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Exact Sciences Corporation | $20.87 | 2025 | The Cologuard Plus Collection Kit |
| Immunogen, INC. | $16.74 | 2023 | Elahere |
| Optumhealth Care Solutions, LLC | $14.28 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Minerva Surgical, INC | $14.23 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norman Bebla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.